由于微生物对现有的发新方抗生素药物的耐药性不断增加，一篇近日发表于在线期刊《PLoS ONE》上的黄酮合物新论文报告了一类潜在的抗微生物分子的合成和测试，以及烟曲霉和隐球菌等真菌。类化" src="https://pic.biodiscover.com/uploads/da4fb5c6e93e74d3df8527599fa62642/article/biodiscover_47985ce0b16f824120.jpg" style="width: 550px; height: 368px; " />
黄酮类及双黄酮类在裸子植物中普遍存在。抗生自来水管道清洗
黄酮类化合物：抗生素药物开发新方向 2011-10-26 17:00 · 李亦奇
由于微生物对现有的抗生素药物的耐药性不断增加，
然而，以便找出更多的有更强大的抗微生物性能的化合物。
相关英文论文摘要：
Development of Non-Natural Flavanones as Antimicrobial Agents
With growing concerns over multidrug resistance microorganisms, particularly strains of bacteria and fungi, evolving to become resistant to the antimicrobial agents used against them, the identification of new molecular targets becomes paramount for novel treatment options. Recently, the use of new treatments containing multiple active ingredients has been shown to increase the effectiveness of existing molecules for some infections, often with these added compounds enabling the transport of a toxic molecule into the infecting species. Flavonoids are among the most abundant plant secondary metabolites and have been shown to have natural abilities as microbial deterrents and anti-infection agents in plants. Combining these ideas we first sought to investigate the potency of natural flavonoids in the presence of efflux pump inhibitors to limit Escherichia coli growth. Then we used the natural flavonoid scaffold to synthesize non-natural flavanone molecules and further evaluate their antimicrobial efficacy on Escherichia coli, Bacillus subtilis and the fungal pathogens Cryptococcus neoformans and Aspergillus fumigatus. Of those screened, we identified the synthetic molecule 4-chloro-flavanone as the most potent antimicrobial compound with a MIC value of 70 µg/mL in E. coli when combined with the inhibitor Phe-Arg-ß-naphthylamide, and MICs of 30 µg/mL in S. cerevesiae and 30 µg/mL in C. neoformans when used alone. Through this study we have demonstrated that combinatorial synthesis of non-natural flavonones can identify novel antimicrobial agents with activity against bacteria and fungi but with minimal toxicity to human cells.
英文论文链接：https://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0025681
科学家们正在寻找药物开发的新方向。并认为他们的治疗效果与许多目前使用的抗微生物剂相当。从而有可能为开发新型抗微生物治疗开创一条新的途径。